Latest FDA News | Page 2

BlinkLab Onboards Vanderbilt Kennedy Center as Seventh U.S. Site for FDA 510(k) Autism Diagnostic Trial
Decades-old drug deployed in fight against mitochondrial diseases
Tackling Ethical Questions About Transcranial Magnetic Stimulation
Avania Strengthens Leadership Team with Appointment of Four New Executives
Pregnant women face tough choices about medication use due to lack of safety data − here’s why medical research cuts will make it worse
FDA approves updated COVID-19 vaccines with new restrictions, potentially limiting access for healthy children
Two years on from Australia’s bold psychedelic experiment, here are our concerns
UWA Steps Up Investment In Cancer Imaging Spinout
How inflammatory bowel disease may accelerate the progression of dementia
The growing fad of ‘microdosing’ mushrooms is leading to an uptick in poison control center calls and emergency room visits
COVID-19 vaccines for kids are mired in uncertainty amid conflicting federal guidance
Vape brands bypass regulations on marketing to young people by using global social media accounts
Longer lashes, lasting damage? What to know about lash serums
WHO recommends injectable lenacapavir for HIV prevention
The AI therapist will see you now: Can chatbots really improve mental health?
Cornell, Wegmans partner to train growers in food safety
‘Gas station heroin’: the drug sold as a dietary supplement that’s linked to overdoses and deaths
RMIT MedTech Invention Goes To Market
BlinkLab (ASX:BB1) Receives U.S. Ethics Approval to Commence Main Phase of FDA 510(k) Diagnostic Trial for Autism
A preservative removed from childhood vaccines 20 years ago is still causing controversy today − a drug safety expert explains
How artificial intelligence controls your health insurance coverage
FDA approval of injectable lenacapavir marks progress for HIV prevention
ICD 2025: New data demonstrate Nemluvio®’s (nemolizumab) favorable safety profile and sustained and clinically meaningful improvements in symptoms of prurigo nodularis up…
Ferrer Receives FDA Fast Track Designation for FNP-223 in Progressive Supranuclear Palsy (PSP)
Epiminder Announces Publication of Landmark Clinical Trial Confirming Safety and Efficacy of the Minder® System
RAD 2025: Long-Term Data on Nemluvio® (nemolizumab) Demonstrate its Favorable Safety Profile and Sustained and Increased Improvements in Itch and Skin Lesions…
Millions of US children have parents with substance use disorder, and the consequences are staggering − new research
HistoSonics’ Edison Histotripsy System Gains Great Britain Early Market Access Under Unmet Clinical Needs Authorisation
RFK Jr. says annual COVID-19 shots no longer advised for healthy children and pregnant women – a public health expert explains the new guidance
For opioid addiction, treatment underdosing can lead to fentanyl overdosing – a physician explains
US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon HADLIMA(TM) (adalimumab-bwwd) Injection
Clue Reaches 1 Million Paid Subscribers, Cementing Position as Leading Data-Driven Women’s Health Intelligence Platform
FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 2025
Junk food is addictive. Drugs like Ozempic treat addiction. But when will we tackle Big Food like we did Big Tobacco?
Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ ß-Amyloid 1-42 Plasma Ratio In-vitro Diagnostic Test as an Aid to Identify Patients…
Placenta bandages have far more health benefits than risky placenta pills − a bioengineer explains
Funding fuels trials for CareTech Human’s health technology
HistoSonics Secures First Major Insurance Coverage for Non-Invasive Histotripsy Treatment for Liver Tumors With Blue Cross Blue Shield of Michigan
Science requires ethical oversight – without federal dollars, society’s health and safety are at risk
Prilenia Enters into a Collaboration and License Agreement with Ferrer for the Commercialization and Co-Development of Pridopidine in Europe and Other Select Markets
The sudden dismissal of public records staff at health agencies threatens government accountability
How bird flu differs from seasonal flu − an infectious disease researcher explains
Gas-sensing capsule takes another big step from lab to commercialisation
Avian flu in raw milk found to be broadly sensitive to heat
BlinkLab Limited Surpasses Key Milestone in Pivotal US Autism Diagnostic Trial
Menthol cigarettes will be banned from April 1. Here’s why – and what else is changing
Massive cuts to Health and Human Services’ workforce signal a dramatic shift in US health policy